Screener
Absci Corporation ABSI Q3 2026 earnings
Reported November 12, 2026 · Before market open
Revenue$304.0KMiss by $353.8K
EPS-$0.19Miss by $0.00
Revenue estimate$657.8K
EPS estimate-$0.19
“As we approach our first look at proof-of-concept data for ABS-201 next month, followed by full data early next year, we are excited for the opportunity to potentially demonstrate our program's ability to stimulate hair regrowth in a convenient and durable way. As ABS-201 progresses through the clinic, we have begun building our commercial infrastructure to support this and potential future programs. In line with that strategy, we are thrilled to be welcoming Gerry Muhle to Absci as our Chief Commercial Officer, whose experience we believe will position ABS-201 and our expanding program pipeline for success.”
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Absci Corporation report Q3 2026 earnings?
- Absci Corporation (ABSI) reported Q3 2026 earnings on November 12, 2026 before market open.
- What were Absci Corporation's Q3 2026 revenue and EPS?
- Absci Corporation reported revenue of $304.0K and eps of $-0.19 for Q3 2026.
- Did Absci Corporation beat estimates in Q3 2026?
- Revenue missed the consensus estimate of $657.8K by $353.8K. EPS missed the consensus estimate of $-0.19 by $0.00.
- How did Absci Corporation's Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 19.6% from $378.0K a year earlier and eps grew 5.0% from $-0.20.
- Where can I find Absci Corporation's Q3 2026 SEC filings?
- You can read the 8-K earnings release (0001672688-26-000150) and the 10-Q periodic report (0001672688-26-000152) directly on SEC EDGAR. The filing index links above go to sec.gov.
